Lilly paid 1.6 Billion for a cancer drug, which ju
Post# of 72440
(Total Views: 397)
Posted On: 10/16/2019 11:17:56 AM
Lilly paid 1.6 Billion for a cancer drug, which just failed.
https://endpts.com/eli-lillys-first-phiii-sho...-what-now/
This is horrible news -- I was hoping that there would finally be a drug that would help against pancreatic cancer.
However, it does show what Kevetrin is really worth. It's a lot more than the market cap for the company now.
Just think, little bashers, what if there is a deal like this for Kevetrin? What will happen to your short positions then?
https://endpts.com/eli-lillys-first-phiii-sho...-what-now/
This is horrible news -- I was hoping that there would finally be a drug that would help against pancreatic cancer.
However, it does show what Kevetrin is really worth. It's a lot more than the market cap for the company now.
Just think, little bashers, what if there is a deal like this for Kevetrin? What will happen to your short positions then?
(5)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼